Role of upper GI endoscopy in the era of immunotherapy – a case series

Aims Immune-checkpoint inhibitors are a fundamental piece in the treatment of several malignancies. These immunotherapies present specific toxicities related to their mechanism of action, commonly referred to as immune-related adverse events (irAE). Among gastrointestinal irAE, upper GI involvement is infrequent, and gastritis is rarely reported.